SYNCOMFUpdated 6 Sept 2026, 19:53

Syncom Formu (i) Ltd

SYNCOMFUpdated 6 Sept 2026, 19:53

Market Cap

₹1,935Cr.

Current Price

₹20.6

High / Low

₹22.6/10.2

Stock P/E

22.8

ROE20.2%

ROCE26.8%

Book Value₹4.39

Face Value₹1.00

Dividend Yield0.49%

About

Established in the year 1995, Syncom Formulations is a global pharmaceutical company that manufactures and markets a broad range of healthcare products. The company is a generic pharmaceutical player operating in more than 15 countries worldwide having more than 400 products registered.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	66	91	91	87	81	77	112	114	124	132	85	81
Inventory Days	34	43	29	37	37	39	51	51	53	49	49	81
Days Payable	63	130	92	75	57	49	66	36	52	33	51	96
Cash Conversion Cycle	37	4	27	49	61	67	96	129	124	148	83	66
Working Capital Days	84	40	45	75	74	88	28	33	-4	51	95	164
ROCE %	16%	15%	14%	9%	9%	12%	21%	11%	10%	10%	19%	27%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 6 September 2026 at 19:53

SYNCOM FORMU (I) LTD (SYNCOMF) financials — quarterly results, P&L, cash flow, balance sheet, shareholding